OSIR Key Statistics, Chart & Performance
The current stock price of OSIR is 18.99 null. In the past month the price decreased by -0.26%. In the past year, price increased by 234.33%.
About OSIR
Company Profile
OSIRIS THERAPEUTICS, INC. is a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas. Osiris currently markets and sells Osteocel for regenerating bone in orthopedic indications. Prochymal is being evaluated in Phase III clinical trials for three indications, including acute and steroid refractory Graft versus Host Disease and also Crohn's disease, and is the only stem cell therapeutic currently designated by FDA as both an Orphan Drug and Fast Track product. Osiris also has partnered with Genzyme Corporation to develop Prochymal as a medical countermeasure to nuclear terrorism and other radiological emergencies. Osiris is a fully integrated company, having developed capabilities in research, development, manufacturing, marketing and distribution of stem cell products.
Company Info
Osiris Therapeutics
7015 ALBERT EINSTEIN DRIVE
COLUMBIA MD 21046
CEO: Jason Keefer
Phone: 443-545-1800
Osiris Therapeutics / OSIR FAQ
What does OSIR do?
OSIRIS THERAPEUTICS, INC. is a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas. Osiris currently markets and sells Osteocel for regenerating bone in orthopedic indications. Prochymal is being evaluated in Phase III clinical trials for three indications, including acute and steroid refractory Graft versus Host Disease and also Crohn's disease, and is the only stem cell therapeutic currently designated by FDA as both an Orphan Drug and Fast Track product. Osiris also has partnered with Genzyme Corporation to develop Prochymal as a medical countermeasure to nuclear terrorism and other radiological emergencies. Osiris is a fully integrated company, having developed capabilities in research, development, manufacturing, marketing and distribution of stem cell products.
What is the stock price of Osiris Therapeutics today?
The current stock price of OSIR is 18.99 null.
Does Osiris Therapeutics pay dividends?
OSIR does not pay a dividend.
What is the ChartMill rating of Osiris Therapeutics stock?
OSIR has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Where is Osiris Therapeutics (OSIR) stock traded?
OSIR stock is listed on the Nasdaq exchange.
OSIR Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to OSIR. When comparing the yearly performance of all stocks, OSIR is one of the better performing stocks in the market, outperforming 99.36% of all stocks.
OSIR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to OSIR. Both the profitability and the financial health of OSIR get a neutral evaluation. Nothing too spectacular is happening here.
OSIR Financial Highlights
Over the last trailing twelve months OSIR reported a non-GAAP Earnings per Share(EPS) of 1.06. The EPS increased by 2750% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 25.84% | ||
| ROA | 36.35% | ||
| ROE | 46.99% | ||
| Debt/Equity | 0 |